These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 9389757)

  • 1. Troglitazone action is independent of adipose tissue.
    Burant CF; Sreenan S; Hirano K; Tai TA; Lohmiller J; Lukens J; Davidson NO; Ross S; Graves RA
    J Clin Invest; 1997 Dec; 100(11):2900-8. PubMed ID: 9389757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
    J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.
    Sreenan S; Keck S; Fuller T; Cockburn B; Burant CF
    Am J Physiol; 1999 Jun; 276(6):E1119-29. PubMed ID: 10362626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.
    Chao L; Marcus-Samuels B; Mason MM; Moitra J; Vinson C; Arioglu E; Gavrilova O; Reitman ML
    J Clin Invest; 2000 Nov; 106(10):1221-8. PubMed ID: 11086023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
    Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
    Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.
    Chen Z; Ishibashi S; Perrey S; Osuga Ji ; Gotoda T; Kitamine T; Tamura Y; Okazaki H; Yahagi N; Iizuka Y; Shionoiri F; Ohashi K; Harada K; Shimano H; Nagai R; Yamada N
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):372-7. PubMed ID: 11231916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
    Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
    Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
    Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
    Furuta M; Yano Y; Gabazza EC; Araki-Sasaki R; Tanaka T; Katsuki A; Hori Y; Nakatani K; Sumida Y; Adachi Y
    Diabetes Res Clin Pract; 2002 Jun; 56(3):159-71. PubMed ID: 11947963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone stimulates pancreatic growth in normal rats.
    Jia DM; Otsuki M
    Pancreas; 2002 Apr; 24(3):303-12. PubMed ID: 11893940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
    Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
    Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
    Oshida Y; Kako M; Nakai N; Shimomura Y; Li L; Sato J; Ohsawa I; Sato Y
    Endocr J; 1999 Oct; 46(5):723-30. PubMed ID: 10670760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats.
    Ide T; Nakazawa T; Mochizuki T; Murakami K
    Metabolism; 2000 Apr; 49(4):521-5. PubMed ID: 10778879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats.
    Inoue I; Takahashi K; Katayama S; Harada Y; Negishi K; Itabashi A; Ishii J
    Metabolism; 1995 Dec; 44(12):1626-30. PubMed ID: 8786734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.
    Kumar S; Boulton AJ; Beck-Nielsen H; Berthezene F; Muggeo M; Persson B; Spinas GA; Donoghue S; Lettis S; Stewart-Long P
    Diabetologia; 1996 Jun; 39(6):701-9. PubMed ID: 8781766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
    Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
    Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
    Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
    J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.